Profil
Edward Samuel is currently working as the SVP-Technical Operations at Achilles Therapeutics Plc since 2022.
Previously, he worked as the Director-Manufacturing at Cognate BioServices, Inc. from 2015 to 2017 and as the Manager-Cell Therapy Operations at Orchard Therapeutics Plc in 2017.
Dr. Samuel holds a doctorate degree from University College London and a graduate degree from King's College London.
Postes actifs de Edward Samuel
| Sociétés | Poste | Début |
|---|---|---|
| ACHILLES THERAPEUTICS PLC | Directeur Technique/Scientifique/R&D | 01/02/2022 |
Anciens postes connus de Edward Samuel
| Sociétés | Poste | Fin |
|---|---|---|
| ORCHARD THERAPEUTICS PLC | Corporate Officer/Principal | 01/12/2017 |
Cognate BioServices, Inc.
Cognate BioServices, Inc. BiotechnologyHealth Technology Manufactures cell-based therapeutics products | Corporate Officer/Principal | 01/05/2017 |
Formation de Edward Samuel
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
University College London
University College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cognate BioServices, Inc.
Cognate BioServices, Inc. BiotechnologyHealth Technology Manufactures cell-based therapeutics products | Health Technology |
King's College London
King's College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Orchard Therapeutics Plc
Orchard Therapeutics Plc BiotechnologyHealth Technology Engages in research and advancements of gene therapy to develop potential cures for genetic & other severe diseases | Health Technology |
Achilles Therapeutics Plc
Achilles Therapeutics Plc Pharmaceuticals: MajorHealth Technology Develops and sells cancer immunotherapies | Health Technology |
















